ENDPOINTS

Compass reports Phase 3 depression data for psilocybin drug

Jun 23, 2025 - 11:40
 0
Compass reports Phase 3 depression data for psilocybin drug
Read More

Tags:

Previous Article

How Asia can be an example in the fight against plastic pollution

Next Article

Quest’s Mega Summer Sale Begins, Bringing up to 50% Off Top VR Titles

Related Posts

ADC Therapeutics reveals layoffs, $100M PIPE; Third Harmonic seeks buyer for asset

ADC Therapeutics reveals layoffs, $100M PIPE; Third Har...

Jun 12, 2025  0

FDA OKs new label expansions for Dupixent and Incyte's Monjuvi

FDA OKs new label expansions for Dupixent and Incyte's ...

Jun 20, 2025  0

#ASCO25: Gilead, Merck reveal 'practice-changing' data for Trodelvy-Keytruda combo in aggressive breast cancer

#ASCO25: Gilead, Merck reveal 'practice-changing' data ...

May 31, 2025  0